Nephros: Funding, Investors & Team (Aug 2026)
Nephros is a commercial-stage company that develops and sells high-performance water purification products to the medical device and commercial markets. The company ultrafilters used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist in improving infection control in showers, sinks, and ice machines. Additionally, Nephros ultrafilters also used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients. The company was founded in 1997 and is based in South Orange, New Jersey, United States.
Nephros has raised $1.2M across 1 funding round on record, the most recent a Post-IPO Equity of $1.2M announced in Jul 2021.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Nephros Company Profile and Key Stats
Latest funding round on record: Jul 2021.
Nephros Funding Rounds
Nephros Founders and Leadership Team
Contact details for the Nephros team: 1 of 1 has an email address on file.
Start 14-day free trial →Nephros Funding Compared to Other Health Care Startups
Nephros' latest round of $1.2M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nephros in Health Care and South Orange
Companies Similar to Nephros
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…
Nephros Funding FAQs
What does Nephros do?
Nephros is a commercial-stage company that develops and sells high-performance water purification products to the medical device and commercial markets. The company ultrafilters used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist in improving infection control in showers, sinks, and ice machines. Additionally, Nephros ultrafilters also used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients. The company was founded in 1997 and is based in South Orange, New Jersey, United States.
How much funding has Nephros raised?
Nephros has raised $1.2M across 1 round on record. The most recent is a Post-IPO Equity of $1.2M announced in Jul 2021.
When did Nephros last raise funding?
Nephros' most recent funding round on record is a Post-IPO Equity of $1.2M, announced in Jul 2021.
Who is the CEO of Nephros?
Andy Astor is listed as CEO at Nephros.
Where is Nephros headquartered?
Nephros is based in South Orange, New Jersey, United States.
How many employees does Nephros have?
Nephros is in the 11-50 employee band.
How does Nephros' funding compare to other Health Care startups?
Nephros' latest round of $1.2M is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Nephros Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nephros is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.